Yew Bio-Pharm Group, Inc.
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a YEWB research report →
Price Chart
About the company
Yew Bio-Pharm Group, Inc. (YEWB) operates as a cultivator and purveyor of yew trees across both the People's Republic of China and the United States, utilizing its subsidiaries. A significant portion of its operations involves supplying raw yew materials, specifically branches and leaves, for the production of Traditional Chinese Medicine (TCM), particularly those containing the compound taxol.
- CEO
- Madam Guifang Qi
- IPO
- 2013
- Employees
- 35
- HQ
- El Monte, CA, US
Get TickerSpark's AI analysis on YEWB
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Similar companies
Peers in the same neighborhood.
- Market Cap
- $11.84K
- P/E
- 0.01
- PEG
- 0.00
- P/S
- 0.00
- P/B
- 0.00
- EV/EBITDA
- 1.84
- Div Yield
- 0.00%
- Gross Margin
- 12.92%
- Op Margin
- 9.41%
- Net Margin
- 5.36%
- ROE
- 3.37%
- ROIC
- 4.42%
Latest fiscal year · YoY change
- Revenue
- $27.31M-2.1%
- Gross Profit
- $3.53M+355.6%
- Op Income
- $2.57M
- Net Income
- $1.46M+48.6%
- EPS
- $0.03+50.0%
- OCF Growth
- +45.1%
- FCF Growth
- +99.4%
- 52W High
- $0.00
- 52W Low
- $0.00
- 50D MA
- $0.00
- 200D MA
- $0.00
- Beta
- -0.68
- RSI (14)
- 1
- Avg Volume
- 0
No earnings-call transcripts are available for YEWB yet.
- Free Float
- 48.9%
- Shares Outstanding
- 59.19M
- Float Shares
- 28.96M
Buy/sell ratio 0.00. Sells can include pre-scheduled 10b5-1 plan sales, not just discretionary selling.
Recent insider transactions
Who's buying, who's selling, and how much.
| Date | Insider | Type | Shares |
|---|---|---|---|
| Oct 6, 15 | Wu Xuehai | other | 0 |
| Dec 2, 19 | Shi Yongchun | other | 0 |
| Dec 2, 19 | Liu Xiefeng | other | 0 |
| Dec 2, 19 | Tian Guoshuang | other | 0 |
| Jan 6, 15 | Han Xingming | sell | 5,000 |
| Jan 6, 15 | Han Xingming | sell | 2,500 |
| Jan 6, 15 | Han Xingming | sell | 10,000 |
| Jan 8, 15 | Han Xingming | sell | 2,700 |
| Jan 8, 15 | Han Xingming | sell | 9,000 |
| Jan 8, 15 | Han Xingming | sell | 5,500 |
A “Sell” may be a pre-scheduled 10b5-1 plan sale rather than a discretionary decision — read insider selling with that in mind.
Our YEWB coverage
Recent articles, reports, and earnings notes.
No research on YEWB yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate YEWB report →